Yoshitomi Pharmaceutical
Industries, Ltd. |
Green Cross Corporation |
|
Tokyo Tanabe Co., Ltd. |
Mitsubishi Chemical
Corporation |
 |
|
1900 |
| 1901 |
 |
Motosaburo Tanabe establishes a druggist house at head offices' present location |
|
|
 |
| 1920 |
| 1921 |
|
Incorporated as Motosaburo Tanabe Shoten |
|
|
Product launch of topical analgesic, Salomethyl |
 |
|
 |
1930 |
| 1936 |
|
Product launch of Japan's first ascorbic acid agent, Ascoltin |
| 1939 |
|
Product launch of Japan's first ascorbic acid agent, Ascoltin |
|
|
Tanabe Company established in Peking and Tanabe Shoten in Hoten, Manchuria in joint ventures with Gohei Tanabe Shoten (present-day Tanabe Seiyaku Co., Ltd.) |
|
| 1934 |
|
Established as Nippon Tar Industries |
|
|
| 1940 |
|
Takeda Kasei Co.,Ltd. is established by Chobei Takeda & Co.,Ltd (present-day Takeda Chemical Industries,Ltd.) and Nippon Kasei Chemical Company Limited (present-day Mitsubishi Chemical Corporation) |
| 1942 |
|
Yoshitomi Plant completed at Higashi-Yoshitomi-mura, Fukuoka prefecture, with production and research
functions |
| 1946 |
|
Trade name changed to Yoshitomi Pharmaceutical Industries, Ltd. |
| 1949 |
|
Listed on Tokyo and Osaka stock exchanges |
|
|
1940 |
| 1940 |
|
Becomes member of newly founded Tokyo Pharmaceutical Wholesale Ltd. |
| 1941 |
|
Tanabe Yoko, founded in Shanghai in partnership with Gohei Tanabe Shoten |
| 1943 |
|
Motosaburo Tanabe establishes a druggist house at head offices' present location |
| 1947 |
|
Production restarted at Oji Plant, largely destroyed in wartime air raid |
|
|
|
| |
| 1950 |
|
Blood Plasma Corporation of Japan established with head office and plant in Osaka |
| 1957 |
|
Listed on Osaka stock exchange |
|
1950 |
| 1952 |
|
Achieves Japan's first successful commercialization of synthetic vitamin B2 |
| 1957 |
|
Product launch of Urso, agent for improvement of liver, gall bladder and digestive functions |
|
| 1952 |
|
Trade name changed to Mitsubishi Chemical Industries, Ltd. |
|
|
| 1961 |
|
Lucidol Yoshitomi, Ltd. (present-day ATOFINA Yoshitomi, Ltd.) established |
| 1968 |
|
Seiwa Kosan, Ltd. (present-day Welfide Service
Corporation) established |
|
|
Pharmopsychiatry Research Foundation (present-day Mitsubishi Pharma Research Foundation) established |
|
| 1964 |
|
Trade name changed to Green Cross Corporation |
| 1968 |
|
Yodogawa Plant completed at Takatsuki, Osaka prefecture |
| 1969 |
|
Taiwan Green Cross Co., Ltd. established as joint venture with Taiwanese enterprise |
|
|
International Reagents Corporation established in Kobe |
|
1960 |
| 1966 |
|
Product launch of Hibon, vitamin preparation for treatment of hypercholesterolemia |
|
|
Oji Plant research section amalgamated with clinical development section to form developmental research department |
|
|
|
| 1970 |
|
Expansion of Central Research Laboratories completed at Yoshitomi Plant |
| 1978 |
|
Seiwa Engineering, Ltd. (present-day Yoshitomi Engineering, Ltd.) established |
|
|
Seiwa Animal Research Laboratory (present-day Seac Yoshitomi, Ltd.) established |
|
| 1978 |
|
Central Distribution Center (present-day Kansai Distribution Center) completed at Neyagawa, Osaka prefecture> |
|
|
Safety Evaluation Laboratories completed at Fukusaki, Hyogo
prefecture |
|
|
Alpha Therapeutic Corporation established in United States |
|
|
Osadano Plant completed at Fukuchiyama, Kyoto prefecture |
|
1970 |
| 1971 |
|
New Ashikaga Plant begins operation |
|
|
Product launch of world's first lactase preparation, Galantase |
|
| 1971 |
|
Pharmaceutical Research Department established |
|
|
Mitsubishi Kasei Institute of Life Sciences (present-day Mitsubishi Kagaku Institute of Life Sciences) established |
| 1976 |
|
Research Center (present-day Yokohama Research Center of Mitsubishi Chemical Corporation) established |
|
|
| 1980 |
|
Independent sale of pharmaceuticals begun |
|
|
Seiwa Warehouse Ltd. (present-day Yoshitomi Warehouse Co., Ltd.) established Welfide Medicinal Research Foundation) established |
| 1984 |
|
Tokyo Research Laboratories moved to upgraded facilities at Iruma, Saitama prefecture |
|
| 1982 |
|
Ryoichi Naito Foundation for Medical Research (present-day Mitsubishi Pharma Research Foundation) established |
| 1987 |
|
Central Research Laboratories moved to upgraded facilities (present-day Osaka Research Laboratories) at Hirakata, Osaka prefecture |
|
1980 |
| 1981 |
|
Business alliance formed with Mitsubishi Chemical Industries, Ltd. (present-day Mitsubishi Chemical Corporation) |
|
|
Product launch of Bonzol, therapeutic agent for endometriosis |
| 1987 |
|
Product launch of pulmonary surfactant preparation for respiratory distress syndrome, Surfacten |
|
| 1984 |
|
|
Product launch of Theodur, a bronchodilator for asthma (first market release) |
| 1986 |
|
Product launch of topical corticosteroid, Myser |
| 1988 |
|
Trade name changed to Mitsubishi Kasei Corporation |
| 1989 |
|
Product launch of long-acting α1-blocker, Vasomet |
|
|
| 1993 |
|
Nabari Training Center completed at Nabari, Mie prefecture |
| 1996 |
|
Chemical products division established as separate company, Yoshitomi Fine Chemicals, Ltd. |
| 1997 |
|
New manufacturing facility completed at Yoshitomi Plant |
|
|
Yoshitomi Research Institute of Neuroscience in
Glasgow (YRING) established in Britain |
|
| 1991 |
|
Green Cross Guangzhou Pharmaceutical Co., Ltd., established in China as joint Japanese-Chinese venture |
| 1994 |
|
Green Cross Corporation of America (present-day Welfide International Corporation) established |
| 1996 |
|
BIPHA CORPORATION established |
|
1990 |
| 1991 |
|
Product launch of antiallergic agent, Alegysal |
| 1993 |
|
Product launch of anti-platelet agent, Anplag |
| 1998 |
|
Kazusa Research Center established at Kazusa Academia Park,Chiba prefecture |
| 1999 |
|
Merger agreement signed with Mitsubishi Chemical Corporation |
|
|
Product launch of hypercholesterolemia agent, Cholebine |
|
| 1994 |
|
Trade name changed to Mitsubishi Chemical Corporation following merger with Mitsubishi Petrochemical Co., Ltd. |
| 1999 |
|
GenCom Co. established as joint venture with Yoshitomi Pharmaceutical Industries, Ltd., and Kyowa
Hakko Co., Ltd., for exploration of human genetic
function |
|
|
| 1998 |
|
Two companies merge as new Yoshitomi Pharmaceutical Industries, Ltd. |
|
| 1999 |
|
Two companies merge and establish subsidiary Mitsubishi-Tokyo Pharmaceuticals, Inc., to take over combined pharmaceutical operations |
|
| 2000 |
|
Trade name changed to Welfide Corporation |
|
Psychiatric Drugs Division is spun off and integrated and with subsidiaries of Welfide Corporation to create Yoshitomiyakuhin Corporation |
|
|
Welfide acquires all shares of affiliate Korea Green Pharm Co., Ltd. |
|
|
Partial transfer of shares in International Reagents Corporation to Sysmex Corporation |
| 2001 |
|
|
Yoshitomiyakuhin Corporation begins co-promotion with Sumitomo Pharmaceuticals Co., Ltd., of antipsychotic Lullan Tablets (perospirone hydrochloride hydrate) |
|
|
Transfer of hospital solutions business and Toyama Plant to Otsuka Pharmaceutical Factory, Inc. |
|
2000 |
| 2000 |
|
Yokohama Research Center and Kazusa Research Center integrated to form Research Center |
| 2001 |
|
MTP Europe Ltd. (present-day Mitsubishi Pharma Europe Ltd.) established in London |
|
|
Product launch of world's first ethical brain-protecting agent, Radicut |
|
| |
| The Creation of Mitsubishi Pharma Corporation |
| |
 |
|
| 2001 |
|
Mitsubishi Pharma America, Inc., and Mitsubishi Pharma Europe Ltd.established (October) |
|
Shanghai Office opened (December) |
|
Sales release of airway secretion cell normalizing agent Cleanal TABLETS 200mg (December) |
| 2002 |
|
Yoshitomiyakuhin Corporation began co-promotion with GlaxoSmithKline of antidepressant Paxil tablet (July) |
|
New quinolone antibacterial agent Pazucross INJECTION released (300mg and 500mg) (September) |
|
Biological Products Division established as separate company Benesis Corporation (October) |
|
API Corporation formed by integrating Yoshitomi Fine Chemicals,Ltd., with the active pharmaceutical ingredients business and part of the fine chemicals business of the Specialty Chemicals Company operated by Mitsubishi Chemical Corporation (October) |
| 2003 |
|
Mitsubishi Pharma Deutschland GmbH established (June) |
|
Mitsubishi Pharma withdraws from US plasma fractionation business by transferring plasma fractionation operations of US subsidiary Alpha Therapeutic Corporation to Probitas Pharma S.A. of Spain (July) and Baxter Healthcare Corporation of US (October) |
|
Active pharmaceutical ingredients business transferred to API Corporation (October) |
|
Healthfood business transferred to IWAKI & CO., LTD. (November) |
| 2004 |
|
OTC pharmaceuticals business transferred to Sato Pharmaceutical Co., Ltd. (March) |
|
VitaminB2 business transferred to DAIICHI Fine Chemical Co., Ltd. (April) |
|
